(LYMH) Multi Units France - Lyxor - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: FR0010405431

Greece, Stock, Market, Tracking, ETF

Description: LYMH Multi Units France - Lyxor

The Multi Units France - Lyxor MSCI Greece UCITS ETF (XETRA:LYMH) is an exchange-traded fund that tracks the Athens Exchange Athex Composite TR Index, providing investors with exposure to the Greek equity market. As a UCITS-compliant ETF, it adheres to stringent European regulatory standards, ensuring a certain level of liquidity, transparency, and investor protection.

With its listing on XETRA, the fund benefits from the liquidity and efficiency of one of Europes premier electronic trading platforms. The ETFs investment objective is to replicate the performance of its underlying index, which comprises a broad representation of the Greek stock market. This makes LYMH an attractive option for investors seeking to gain exposure to Greeces economic recovery and growth prospects.

Analyzing the , we observe a positive short-term trend, as indicated by the last price (1.95) being above both the SMA20 (1.86) and SMA50 (1.81). The SMA200 (1.61) suggests a longer-term uptrend. The ATR (0.05) represents a 2.41% daily volatility, which is relatively moderate. Considering the 52-week high (1.95) and low (1.41), the current price is at its highest level over the past year, indicating a strong recovery.

From a fundamental perspective, the funds AUM (149.84M EUR) indicates a reasonable level of investor interest. Given the Greek economys gradual recovery and the potential for continued growth, its plausible that the ETF could attract further investment, potentially driving its AUM higher.

Forecasting the ETFs performance, we can consider both technical and fundamental factors. The ongoing uptrend, as supported by the SMA20, SMA50, and SMA200, suggests a continued positive outlook. Additionally, Greeces economic growth prospects, coupled with the ETFs relatively low AUM, could attract more investors, potentially driving the price higher. Based on these factors, a reasonable forecast would be for the ETF to trade within a range of 2.00-2.20 in the near term, representing a potential upside of 2.5-12.8% from the current price.

Additional Sources for LYMH ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

LYMH ETF Overview

Market Cap in USD 177m
Category Other Equity
TER 0.45%
IPO / Inception 2007-01-05

LYMH ETF Ratings

Growth Rating 95.2
Fundamental -
Dividend Rating 73.4
Rel. Strength 13
Analysts -
Fair Price Momentum 2.56 EUR
Fair Price DCF -

LYMH Dividends

Dividend Yield 12m 3.22%
Yield on Cost 5y 9.23%
Annual Growth 5y 43.10%
Payout Consistency 83.8%
Payout Ratio %

LYMH Growth Ratios

Growth Correlation 3m 93.5%
Growth Correlation 12m 86.5%
Growth Correlation 5y 94.2%
CAGR 5y 26.63%
CAGR/Max DD 5y 1.18
Sharpe Ratio 12m 1.97
Alpha 35.12
Beta 0.415
Volatility 14.83%
Current Volume 353.2k
Average Volume 20d 138k
What is the price of LYMH shares?
As of July 06, 2025, the stock is trading at EUR 2.16 with a total of 353,236 shares traded.
Over the past week, the price has changed by +2.89%, over one month by +5.60%, over three months by +26.60% and over the past year by +45.05%.
Is Multi Units France - Lyxor a good stock to buy?
Yes. Based on ValueRay's Analyses, Multi Units France - Lyxor (XETRA:LYMH) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 95.15 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYMH is around 2.56 EUR . This means that LYMH is currently undervalued and has a potential upside of +18.52% (Margin of Safety).
Is LYMH a buy, sell or hold?
Multi Units France - Lyxor has no consensus analysts rating.
What are the forecasts for LYMH share price target?
According to our own proprietary Forecast Model, LYMH Multi Units France - Lyxor will be worth about 2.9 in July 2026. The stock is currently trading at 2.16. This means that the stock has a potential upside of +31.94%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 2.9 31.9%